Prof.Dr.Med. ID: 42745

Guido Sauter

graph of relations

Publications

  1. 2009
  2. Unilateral prostate cancer cannot be accurately predicted in low-risk patients.

    Isbarn, H., Karakiewicz, P. I., Vogel, S., Jeldres, C., Lughezzani, G., Briganti, A., Montorsi, F., Perrotte, P., Ahyai, S. A., Budäus, L., Eichelberg, C., Heuer, R., Köllermann, J., Sauter, G., Schlomm, T., Steuber, T., Haese, A., Zacharias, M., Fisch, M., Heinzer, H., Huland, H., Chun, F. & Graefen, M., 2009, In: INT J RADIAT ONCOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2008
  4. Versagensgründe von Oberflächenersatzimplantaten der Hüfte. Eine Analyse von 250 Revisionspräparaten

    Morlock, M. M., Bishop, N., Stahmer, F., Zustin, J., Sauter, G., Hahn, M., Krause, M., Rüther, W. & Amling, M., 01.07.2008, In: ORTHOPADE. 37, 7, p. 695-703 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. AMACR expression in colorectal cancer is associated with left-sided tumor localization.

    Marx, A., Simon, P., Simon, R., Mirlacher, M., Izbicki, J. R., Yekebas, E. F., Kaifi, J., Terracciano, L. & Sauter, G., 2008, In: VIRCHOWS ARCH. 453, 3, p. 243-248 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Clinical significance of p53 alterations in surgically treated prostate cancers.

    Schlomm, T., Iwers, L., Kirstein, P., Jessen, B., Köllermann, J., Minner, S., Passow-Drolet, A., Mirlacher, M., Milde-Langosch, K., Graefen, M., Haese, A., Steuber, T., Simon, R., Huland, H., Sauter, G. & Erbersdobler, A., 2008, In: MODERN PATHOL. 21, 11, p. 1371-1378 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. [Crystal-induced arthropathies]

    Zustin, J., Fuerst, M., Sauter, G. & Rüther, W., 2008, In: Z RHEUMATOL. 67, 1, p. 47-50 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.

    Jehan, Z., Siraj, A. K., Abubaker, J., Ruiz, C., Simon, R., Sultana, M., Uddin, S., Bavi, P., Hussain, A., Razack, S., Ezzat, A., Al-Dayel, F., Sauter, G. & Al-Kuraya, K. S., 2008, In: ONCOLOGY-BASEL. 75, 1-2, p. 71-80 1-2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

    Fleischmann, A., Schlomm, T., Huland, H., Köllermann, J., Simon, P., Mirlacher, M., Salomon, G., Chun, F., Steuber, T., Simon, R., Sauter, G., Graefen, M. & Erbersdobler, A., 2008, In: CLIN CANCER RES. 14, 23, p. 7838-7842 23.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Estrogen receptor gene amplification occurs rarely in ovarian cancer.

    Issa, R., Lebeau, A., Grob, T., Holst, F., Moch, H., Terracciano, L., Choschzick, M., Sauter, G. & Simon, R., 2008, In: MODERN PATHOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Expression and prognostic relevance of annexin A3 in prostate cancer.

    Köllermann, J., Schlomm, T., Bang, H., Schwall, G. P., von Eichel-Streiber, C., Simon, R., Schostak, M., Huland, H., Berg, W., Sauter, G., Klocker, H. & Schrattenholz, A., 2008, In: EUR UROL. 54, 6, p. 1314-1323 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Immunohistochemical profiling of Wilms tumor: a tissue microarray study.

    Vasei, M., Moch, H., Mousavi, A., Kajbafzadeh, A. M. & Sauter, G., 2008, In: APPL IMMUNOHISTO M M. 16, 2, p. 128-134 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Is it time for a new TNM classification in esophageal carcinoma?

    Bogoevski, D., Onken, F., König, A., Kaifi, J., Schurr, P., Sauter, G., Izbicki, J. R. & Yekebas, E. F., 2008, In: ANN SURG. 247, 4, p. 633-641 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.

    Fiegel, H. C., Kaifi, J., Quaas, A., Varol, E., Krickhahn, A., Metzger, R., Sauter, G., Till, H., Izbicki, J. R., Erttmann, R. & Kluth, D., 2008, In: PEDIATR SURG INT. 24, 1, p. 101-105 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Marked gene transcript level alterations occur early during radical prostatectomy.

    Schlomm, T., Näkel, E., Lübke, A., Buness, A., Chun, F., Steuber, T., Graefen, M., Simon, R., Sauter, G., Poustka, A., Huland, H., Erbersdobler, A., Sültmann, H. & Hellwinkel, O., 2008, In: EUR UROL. 53, 2, p. 333-344 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.

    Lebeau, A., Grob, T., Holst, F., Seyedi-Fazlollahi, N., Moch, H., Terracciano, L., Turzynski, A., Choschzick, M., Sauter, G. & Simon, R., 2008, In: J PATHOL. 216, 2, p. 151-157 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.

    Cour, L., Jonas, M., Høj, B. R., Simon, R., Sauter, G., Sauter, G. & Berchtold, M. W., 2008, In: MOL ONCOL. 1, 4, p. 431-439 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2007
  19. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

    Schlomm, T., Kirstein, P., Iwers, L., Daniel, B., Steuber, T., Walz, J., Chun, F., Haese, A., Köllermann, J., Graefen, M., Huland, H., Sauter, G., Simon, R. & Erbersdobler, A., 2007, In: CLIN CANCER RES. 13(22 Pt 1), p. 6579-6584

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.

    Tapia, C., Glatz, K., Novotny, H., Lugli, A., Horcic, M., Seemayer, C. A., Tornillo, L., Terracciano, L., Spichtin, H., Mirlacher, M., Simon, R. & Sauter, G., 2007, In: MODERN PATHOL. 20, 2, p. 192-198 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

    Holst, F., Stahl, P., Ruiz, C., Hellwinkel, O., Jehan, Z., Wendland, M., Lebeau, A., Terracciano, L., Al-Kuraya, K., Jänicke, F., Sauter, G. & Simon, R., 2007, In: NAT GENET. 39, 5, p. 655-660 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.

    Reichelt, U., Duesedau, P., Tsourlakis, M. C., Quaas, A., Link, B-C., Schurr, P., Kaifi, J., Gros, S., Yekebas, E. F., Marx, A., Simon, R., Izbicki, J. R. & Sauter, G., 2007, In: MODERN PATHOL. 20, 1, p. 120-129 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

    Dahl, E., Wiesmann, F., Woenckhaus, M., Stoehr, R., Wild, P. J., Veeck, J., Knüchel, R., Klopocki, E., Sauter, G., Simon, R., Wieland, W. F., Walter, B., Denzinger, S., Hartmann, A. & Hammerschmied, C. G., 2007, In: ONCOGENE. 26, 38, p. 5680-5691 38.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody.

    Mhawech-Fauceglia, P., Herrmann, F. R., Bshara, W., Odunsi, K., Terracciano, L., Sauter, G., Cheney, R. T., Groth, J. & Penetrante, R., 2007, In: J CLIN PATHOL. 60, 6, p. 694-700 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

    Al-Kuraya, K., Novotny, H., Bavi, P., Siraj, A. K., Uddin, S., Ezzat, A., Sanea, N. A., Al-Dayel, F., Al-Mana, H., Sheikh, S. S., Mirlacher, M., Tapia, C., Simon, R., Sauter, G., Terracciano, L. & Tornillo, L., 2007, In: J CLIN PATHOL. 60, 7, p. 768-772 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.

    Olejniczak, E. T., Charles, V. S., Anderson, M. G., Wang, G., Tahir, S. K., Sauter, G., Lesniewski, R. & Semizarov, D., 2007, In: MOL CANCER RES. 5, 4, p. 331-339 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.

    Wachowiak, R., Fiegel, H., Kaifi, J., Quaas, A., Krickhahn, A., Schurr, P., Erttmann, R., Schachner, M., Kluth, D., Sauter, G. & Izbicki, J. R., 2007, In: ANN SURG ONCOL. 14, 12, p. 3575-3580 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer.

    Kaifi, J., Reichelt, U., Quaas, A., Schurr, P., Wachowiak, R., Yekebas, E. F., Strate, T., Schneider, C. G., Pantel, K., Schachner, M., Sauter, G. & Izbicki, J. R., 2007, In: MODERN PATHOL. 20, 11, p. 1183-1190 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.

    Eiber, M., Oers, V., Johanna, M. M., Zwarthoff, E. C., Kwast, V. D., Theo, H., Ulrich, O., Helpap, B., Stoerkel, S., Sauter, G., Cheville, J., Sauter, G., Wild, P. J., Stoehr, R., Hofstaedter, F. & Hartmann, A., 2007, In: AM J SURG PATHOL. 31, 6, p. 938-946 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. [Molecular biology studies of late recurrence of testicular cancers]

    Albers, P., Honecker, F., Rüschoff, J., Sauter, G., Müller, S. C., Büttner, R. & Bokemeyer, C., 2007, In: UROLOGE. 46, 9, p. 1185-1186 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. [Molecular high throughput research in prostate carcinoma]

    Schlomm, T., Sültmann, H., Poustka, A., Sauter, G., Hellwinkel, O. & Huland, H., 2007, In: UROLOGE. 46, 9, p. 1097-1100 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Molecular staging of prostate cancer in the year 2007.

    Schlomm, T., Erbersdobler, A., Mirlacher, M. & Sauter, G., 2007, In: WORLD J UROL. 25, 1, p. 19-30 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

    Woenckhaus, M., Bubendorf, L., Dalquen, P., Foerster, J., Blaszyk, H., Mirlacher, M., Soler, M., Dietmaier, W., Sauter, G., Hartmann, A. & Wild, P. J., 2007, In: J CLIN PATHOL. 60, 5, p. 483-486 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis.

    Mhawech-Fauceglia, P., Saxena, R., Zhang, S., Terracciano, L., Sauter, G., Chadhuri, A., Herrmann, F. R. & Penetrante, R., 2007, In: J CLIN PATHOL. 60, 6, p. 709-714 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.

    Tornillo, L., Lugli, A., Zlobec, I., Willi, N., Glatz, K., Lehmann, F., Spichtin, H-P., Maurer, R., Stoios, D., Sauter, G. & Terracciano, L., 2007, In: AM J CLIN PATHOL. 127, 1, p. 114-123 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

    Mhawech-Fauceglia, P., Zhang, S., Terracciano, L., Sauter, G., Chadhuri, A., Herrmann, F. R. & Penetrante, R., 2007, In: HISTOPATHOLOGY. 50, 4, p. 472-483 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.

    Kaifi, J., Rawnaq, T., Schurr, P., Yekebas, E. F., Mann, O., Merkert, P., Link, B-C., Kalinin, V., Pantel, K., Sauter, G., Strate, T. & Izbicki, J. R., 2007, In: AM J SURG. 194, 3, p. 380-384 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.

    Wachowiak, R., Kaifi, J., Schurr, P., Merkert, P., Yekebas, E. F., Schwarzenbach, H., Strate, T., Sauter, G. & Izbicki, J. R., 2007, In: ANTICANCER RES. 27, 1, p. 477-481 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. 2006
  40. Abundant expression of AMACR in many distinct tumour types.

    Went, P. T., Sauter, G., Oberholzer, M. & Bubendorf, L., 2006, In: PATHOLOGY. 38, 5, p. 426-432 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

    Linke, S. P., Bremer, T. M., Herold, C. D., Sauter, G. & Diamond, C., 2006, In: CLIN CANCER RES. 12, 4, p. 1175-1183 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects.

    Klass, D. M., Bührmann, K., Sauter, G., Del Puppo, M., Scheibner, J., Fuchs, M. & Stange, E. F., 2006, In: ALIMENT PHARM THER. 23, 7, p. 895-905 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.

    Al-Kuraya, K. S., Bavi, P. P., Ezzat, A. A., Al-Dayel, F. A., Uddin, S., Atizado, V. L., Al-Jomah, N. A., Amr, S. S., Sheikh, S. S., Sauter, G. & Simon, R., 2006, In: SAUDI MED J. 27, 3, p. 323-328 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.

    Wu, K., Li, A., Rao, M., Liu, M., Dailey, V., Yang, Y., Dolores, D. V., Wang, C., Lisanti, M. P., Sauter, G., Russell, R. G., Cvekl, A. & Pestell, R. G., 2006, In: MOL CELL BIOL. 26, 19, p. 7116-7129 19.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.

    Oeggerli, M., Schraml, P., Ruiz, C., Bloch, M., Novotny, H., Mirlacher, M., Sauter, G. & Simon, R., 2006, In: ONCOGENE. 25, 49, p. 6538-6543 49.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Epithelial growth factor receptor status in primary and recurrent ovarian cancer.

    Stadlmann, S., Gueth, U., Reiser, U., Diener, P-A., Zeimet, A. G., Wight, E., Mirlacher, M., Sauter, G., Mihatsch, M. J. & Singer, G., 2006, In: MODERN PATHOL. 19, 4, p. 607-610 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia.

    Al-Kuraya, K., Narayanappa, R., Al-Dayel, F., El-Solh, H., Ezzat, A., Ismail, H., Belgaumi, A., Bavi, P., Atizado, V., Sauter, G. & Simon, R., 2006, In: LEUKEMIA LYMPHOMA. 47, 4, p. 707-713 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva.

    Pache, M., Glatz-Krieger, K., Sauter, G. & Meyer, P., 2006, In: GRAEF ARCH CLIN EXP. 244, 1, p. 113-117 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

    Went, P., Vasei, M., Bubendorf, L., Terracciano, L., Tornillo, L., Riede, U., Kononen, J., Simon, R., Sauter, G. & Baeuerle, P. A., 2006, In: BRIT J CANCER. 94, 1, p. 128-135 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.

    Al-Kuraya, K., Narayanappa, R., Siraj, A. K., Al-Dayel, F., Ezzat, A., Hassan, E. S., Al-Jommah, N., Sauter, G. & Simon, R., 2006, In: HUM PATHOL. 37, 6, p. 742-748 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. High incidence of EMMPRIN expression in human tumors.

    Riethdorf, S., Reimers, N., Assmann, V., Kornfeld, J-W., Terracciano, L., Sauter, G. & Pantel, K., 2006, In: INT J CANCER. 119, 8, p. 1800-1810 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.

    Khawla, A. K., Siraj, A. K., Bavi, P., Al-Jomah, N., El-Solh, H., Ezzat, A., Al-Dayel, F., Belgaumi, A., Amani, A-K., Sabbah, R., Sheikh, S., Amr, S., Simon, R. & Sauter, G., 2006, In: MODERN PATHOL. 19, 8, p. 1124-1129 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. L1 (CD171) is highly expressed in gastrointestinal stromal tumors.

    Kaifi, J., Strelow, A., Schurr, P., Reichelt, U., Yekebas, E. F., Wachowiak, R., Quaas, A., Strate, T., Schaefer, H., Sauter, G., Schachner, M. & Izbicki, J. R., 2006, In: MODERN PATHOL. 19, 3, p. 399-406 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.

    Law, C-L., Gordon, K. A., Toki, B. E., Yamane, A. K., Hering, M. A., Cerveny, C. G., Petroziello, J. M., Ryan, M. C., Smith, L., Simon, R., Sauter, G., Oflazoglu, E., Doronina, S. O., Meyer, D. L., Francisco, J. A., Carter, P., Senter, P. D., Copland, J. A., Wood, C. G. & Wahl, A. F., 2006, In: CANCER RES. 66, 4, p. 2328-2337 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1...6 7 8 9 10 11 Next